0001485003-17-000004.txt : 20170216
0001485003-17-000004.hdr.sgml : 20170216
20170216170948
ACCESSION NUMBER: 0001485003-17-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170214
FILED AS OF DATE: 20170216
DATE AS OF CHANGE: 20170216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCCABE JOHN J
CENTRAL INDEX KEY: 0001205535
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 17618721
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC.
STREET 2: 215 FIRST STREET, SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_148728297397095.xml
FORM 4
X0306
4
2017-02-14
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001205535
MCCABE JOHN J
C/O ELEVEN BIOTHERAPEUTICS, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Common Stock
2017-02-14
4
S
0
1399
2.10
D
5930
D
The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.
/s/ John J. McCabe
2017-02-16